Naltrexone in the Treatment of Alcohol Dependence

Cited by (618)

Items 201–300 of 618

1. Sensitization of Incentive Salience and the Transition to Addiction
   Shelley M. Warlow, Hannah M. Baumgartner, Charlotte M. Freeland, Erin E. Naffziger, Jeffrey J. Olney, Kent C. Berridge, Mike J.F. Robinson · 2020 · Cambridge University Press eBooks
2. Medications for treating alcohol use disorder: A narrative review
   Henry R. Kranzler, Emily E. Hartwell · 2023 · Alcoholism Clinical and Experimental Research
3. Extended-release naltrexone for treatment of alcohol dependence in primary care
   Joshua D. Lee, Ellie Grossman, Danae DiRocco, Andrea Truncali, Kathleen Hanley, David L. Stevens, John Rotrosen, Marc N. Gourevitch · 2010 · Journal of Substance Abuse Treatment
4. Management of Pruritus in Primary Biliary Cholangitis: A Narrative Review
   Hirsh D. Trivedi, Blanca Lizaola‐Mayo, Elliot B. Tapper, Alan Bonder · 2017 · The American Journal of Medicine
5. Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia: Integrated alcohol and TB treatment in Tomsk, Russia
   Shin, Sonya, Livchits, Viktoria, Connery, Hilary Smith, Shields, Alan, Yanov, Sergei, Yanova, Galina, Fitzmaurice, Garrett M., Nelson, Adrianne K., Greenfield, Shelly F., Tomsk Tuberculosis Alcohol Working Group · 2013 · Addiction
6. Considering the Overlap and Nonoverlap of Compulsivity, Impulsivity, and Addiction
   Austin W. Blum, Jon Edgar Grant · 2020 · Cambridge University Press eBooks
7. Neurobiology of Substance Addictions
   Nina Caitlin Christie, Antoine Bechara · 2020 · Cambridge University Press eBooks
8. Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers
   Niamh Fitzgerald, Kathryn Angus, Andrew Elders, Marisa de Andrade, Duncan Raistrick, Nick Heather, Jim McCambridge · 2016 · Addiction
9. Targeted Naltrexone Treatment Moderates the Relations Between Mood and Drinking Behavior Among Problem Drinkers.
   Henry R. Kranzler, Stephen Armeli, Richard Feinn, Howard A. Tennen · 2004 · Journal of Consulting and Clinical Psychology
10. Mindfulness-Based Interventions Applied to Addiction Treatments
    Afton Kechter, David Scott Black · 2020 · Cambridge University Press eBooks
11. Multiple Memory Systems, Addiction, and Health Habits: New Routes for Translational Science
    Alan W. Stacy, James Russell Pike, Anna Yu Lee · 2020 · Cambridge University Press eBooks
12. Tanning as an Addiction: The State of the Research and Implications for Intervention
    Kimberly Ann Miller, Darren M. Mays · 2020 · Cambridge University Press eBooks
13. Food versus Eating Addictions
    Erica M. Schulte, Emma T. Schiestl, Ashley Nicole Gearhardt · 2020 · Cambridge University Press eBooks
14. Alcohol Use in Polish 9/11 Responders
    Craig L. Katz, Didier Jutras‐Aswad, Marta Kiliman, Iwona Pilatowicz, Evaristo Akerele, Kathryn Marrone, Fatih Özbay · 2012 · Journal of Psychiatric Practice
15. Behavioral Economics and Addictive Disorders
    David P. Jarmolowicz, Tadd D. Schneider · 2020 · Cambridge University Press eBooks
16. Prevention and Treatment of Compulsive Buying Disorder
    Artur Galimov, Donald W. Black · 2020 · Cambridge University Press eBooks
17. Precision Behavioral Management (PBM): A Novel Genetically Guided Therapy to Combat Reward Deficiency Syndrome (RDS) Relevant to the Opiate Crisis
    Kenneth Blum, Alphonse Kenison Roy, Arwen Podesta, Edward Justin Modestino, Bruce Steinberg, Marjorie C. Gondré-Lewis, David A. Baron, Panayotis K. Thanos, Lisa Lott, Sampada Badgaiyan et al. · 2020 · Cambridge University Press eBooks
18. Prevention and Treatment of “Food Addiction”
    Caroline Davis, Ashley E. Mason · 2020 · Cambridge University Press eBooks
19. Human Neurobiological Approaches to Hedonically Motivated Behaviors
    Kyle Stanley Burger, Grace Elisabeth Shearrer, Jennifer R. Sadler · 2020 · Cambridge University Press eBooks
20. Feedback Models for Gambling Control: The Use and Efficacy of Online Responsible Gambling Tools
    Mark Damian Griffiths · 2020 · Cambridge University Press eBooks
21. Anti‐dipsotropic isoflavones: The potential therapeutic agents for alcohol dependence
    Wing Ming Keung · 2003 · Medicinal Research Reviews
22. Variable Selection for Qualitative Interactions in Personalized Medicine While Controlling the Family-Wise Error Rate
    Lacey Gunter, Ji Zhu, Susan A. Murphy · 2011 · Journal of Biopharmaceutical Statistics
23. OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence
    Janet K. Coller, Sharon Cahill, Carolyn Edmonds, Aaron L. Farquharson, Marie C. Longo, Rinaldo Minniti, Thomas Sullivan, Andrew Alexander Somogyi, Jason M. White · 2011 · Pharmacogenetics and Genomics
24. The µ-Opioid Receptor and Treatment Response to Naltrexone
    Annika Thorsell · 2013 · Alcohol and Alcoholism
25. Specific and Nonspecific Effects of Naltrexone on Goal-Directed and Habitual Models of Alcohol Seeking and Drinking
    Rachel A. Hay, Joshua H. Jennings, Dawnya L. Zitzman, Clyde W. Hodge, Donita L. Robinson · 2013 · Alcoholism Clinical and Experimental Research
26. Emerging approaches to managing alcohol dependence
    Robert M. Swift · 2007 · American Journal of Health-System Pharmacy
27. Addiction Psychiatry and Addiction Medicine: The Evolution of Addiction Physician Specialists
    Edward V. Nunes, Kevin Kunz, Marc S. Galanter, Patrick G. O’Connor · 2020 · American Journal on Addictions
28. Development of a mouse model of ethanol addiction: naltrexone efficacy in reducing consumption but not craving
    Debora Joana Fachin Scheit, Andrea Frozino Ribeiro, G. Pigatto, F.O. Goeldner, Roseli Boerngen de Lacerda · 2006 · Journal of Neural Transmission
29. Emerging drugs to treat alcoholism
    Michael Soyka, Susanne Rösner · 2010 · Expert Opinion on Emerging Drugs
30. The treatment of alcohol dependence
    Sawitri Assanangkornchai, Manit Srisurapanont · 2007 · Current Opinion in Psychiatry
31. New pharmacological approaches for the treatment of alcoholism
    Michael Soyka, Susanne Rösner · 2006 · Expert Opinion on Pharmacotherapy
32. A double‐blind, placebo‐controlled study of naltrexone in the treatment of alcohol dependence in Taiwan
    Ming‐Chyi Huang, C.-Y. Oliver Chen, Jeng‐Ming Yu, Chiao‐Chicy Chen · 2005 · Addiction Biology
33. CLINICAL STUDY: Cloninger’s typology and treatment outcome in alcohol‐dependent subjects during pharmacotherapy with naltrexone
    Falk Kiefer, Miguel Ángel Jiménez‐Arriero, Oliver Klein, Alexander Diehl, Gabriel Rubio · 2007 · Addiction Biology
34. Combining Naltrexone and Prazosin in a Single Oral Medication Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone
    Janice C. Froehlich, Brett J. Hausauer, Dennis D. Rasmussen · 2013 · Alcoholism Clinical and Experimental Research
35. Role of State Policies in the Adoption of Naltrexone for Substance Abuse Treatment
    Carolyn J. Heinrich, Carolyn J. Hill · 2007 · Health Services Research
36. Management of Alcoholic Liver Disease
    Michael Ronan Lucey · 2009 · Clinics in Liver Disease
37. An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence
    Bankole A. Johnson · 2004 · Expert Opinion on Pharmacotherapy
38. A Randomized Trial of Peer-Delivered Self-Management Support for Hypertension
    Jeff Whittle, Marilyn M. Schapira, Kenneth E. Fletcher, A. Hayes, Jeffrey A. Morzinski, Purushottam W. Laud, Dan C. Eastwood, Kristyn Ertl, L. Patterson, Katie E. Mosack · 2014 · American Journal of Hypertension
39. What Place Does Naltrexone Have in the Treatment of Alcoholism?
    Damaris J. Rohsenow · 2004 · CNS Drugs
40. Using Stated Preference Modeling to Forecast the Effect of Medication Attributes on Prescriptions of Alcoholism Medications
    Tami L. Mark, Joffre Swait́ · 2003 · Value in Health
41. Rats on the grog: Novel pharmacotherapies for alcohol craving
    Iain S. McGregor, Jason E. Gallate · 2004 · Addictive Behaviors
42. The preclinical development of Medisorb® Naltrexone, a once a month long-acting injection, for the treatment of alcohol dependence
    L. Dean Reginald · 2005 · Frontiers in bioscience
43. Use of Acamprosate and Opioid Antagonists in the Treatment of Alcohol Dependence: A European Perspective
    Michael Soyka, Jonathan Chick · 2003 · American Journal on Addictions
44. Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics.
    Damaris J. Rohsenow, Robert Miranda, John E. McGeary, Peter M. Monti · 2007 · Experimental and Clinical Psychopharmacology
45. Applications of Pueraria lobata in treating diabetics and reducing alcohol drinking
    Jing Liu, Yeu‐Ching Shi, David Y.W. Lee · 2019 · Chinese Herbal Medicines
46. Galantamine: a cholinergic patch in the treatment of alcoholism: a randomized, placebo-controlled trial
    Karl F Mann, Klaus Ackermann, Alexander Diehl, D. Ebert, Goetz Mundle, Helmut Nakovics, Thomas Reker, G. Richter, Lutz Schmidt, Martin Drießen et al. · 2005 · Psychopharmacology
47. Effects of Alcoholism Typology on Response to Naltrexone in the COMBINE Study
    Michael P. Bogenschutz, J. Scott Tonigan, Helen M. Pettinati · 2008 · Alcoholism Clinical and Experimental Research
48. Short‐term treatment of post‐traumatic stress disorder with naltrexone: an open‐label preliminary study
    Gadi Lubin, Abraham Weizman, Mordechai Shmushkevitz, Avi Valevski · 2002 · Human Psychopharmacology Clinical and Experimental
49. The Opioidergic-Alcohol Link
    Vania Modesto‐Lowe, Eleanor M. Fritz · 2005 · CNS Drugs
50. Endogenous opiates and behavior: 2001
    Richard J. Bodnar, Maria M. Hadjimarkou · 2002 · Peptides
51. Polymorphisms in the µ-Opioid Receptor Gene ( OPRM1 ) and the Implications for Alcohol Dependence in Humans
    Carmen S. van der Zwaluw, Esther Van Den Wildenberg, Reinout W. H. J. Wiers, Barbara Franke, Jan K. Buitelaar, Ron H. J. Scholte, Rutger C. M. E. Engels · 2007 · Pharmacogenomics
52. Naltrexone ameliorates functional network abnormalities in alcohol‐dependent individuals
    Laurel S. Morris, Kwangyeol Baek, Roger J. Tait, Rebecca Elliott, Karen D. Ersche, Remy Flechais, John McGonigle, Anna Murphy, Liam J. Nestor, Csaba Orbán et al. · 2017 · Addiction Biology
53. Pharmacogenetics of alcohol use disorder treatments: an update
    Emily E. Hartwell, Henry R. Kranzler · 2019 · Expert Opinion on Drug Metabolism & Toxicology
54. Acute naltrexone does not remediate fronto‐striatal disturbances in alcoholic and alcoholic polysubstance‐dependent populations during a monetary incentive delay task
    Liam J. Nestor, Anna Murphy, John McGonigle, Csaba Orbán, Laurence John Reed, Eleanor Taylor, Remy Flechais, Louise M. Paterson, Dana G. Smith, Edward Thomas Bullmore et al. · 2016 · Addiction Biology
55. Development of medications for alcohol use disorders: recent advances and ongoing challenges
    Raye Z. Litten, Joanne B. Fertig, Margaret E. Mattson, Mark Egli · 2005 · Expert Opinion on Emerging Drugs
56. Development of Novel Pharmacotherapies for the Treatment of Alcohol Dependence: Focus on Antiepileptics
    Bankole A. Johnson, Robert M. Swift, Nassima Ait‐Daoud, Carlo C. DiClemente, Martin A. Javors, Robert J Malcolm · 2004 · Alcoholism Clinical and Experimental Research
57. Combining Psychosocial Treatment with Pharmacotherapy for Alcohol Dependence
    Roger D. Weiss, Karsten D. Kueppenbender · 2006 · Journal of Clinical Psychopharmacology
58. Sulfation of opioid drugs by human cytosolic sulfotransferases: Metabolic labeling study and enzymatic analysis
    Katsuhisa Kurogi, Andriy Chepak, Michael T. Hanrahan, Ming‐Yih Liu, Yoichi Sakakibara, Masahito Suiko, Ming-Cheh Liu · 2014 · European Journal of Pharmaceutical Sciences
59. On treatment mechanisms—what can we learn from the COMBINE study?
    Anders Bergmark · 2008 · Addiction
60. Does matching matter? Examining matches and mismatches between patient attributes and therapy techniques in alcoholism treatment
    Mitchell P. Karno, Richard Longabaugh · 2007 · Addiction
61. COMPARISON OF CYANAMIDE AND PLACEBO IN THE TREATMENT OF ALCOHOL DEPENDENCE OF ADOLESCENTS
    Helmut Niederhofer, Wolfgang Staffen, A. Mair · 2003 · Alcohol and Alcoholism
62. Pharmacotherapies and Personalized Medicine for Alcohol Use Disorder: A Review
    Falk W. Lohoff · 2020 · Pharmacogenomics
63. A Call to Action: A Systematic Review Examining the Failure to Include Females and Members of Minoritized Racial/Ethnic Groups in Clinical Trials of Pharmacological Treatments for Alcohol Use Disorder
    Melissa R. Schick, Nichea S. Spillane, Katherine L. Hostetler · 2020 · Alcoholism Clinical and Experimental Research
64. Update on the Treatment of the Pruritus of Cholestasis
    Nora V. Bergasa · 2008 · Clinics in Liver Disease
65. The Alcohol Clinical Trials Initiative (ACTIVE): Purpose and Goals for Assessing Important and Salient Issues for Medications Development in Alcohol Use Disorders
    the ACTIVE Workgroup, Raymond F. Anton, Raye Z. Litten, Daniel E. Falk, Joseph Palumbo, Raymond T. Bartus, Rebecca L. Robinson, Henry R. Kranzler, Thomas R. Kosten, Roger E. Meyer et al. · 2011 · Neuropsychopharmacology
66. Efficacy and Safety of the Glycine Transporter‐1 Inhibitor Org 25935 for the Prevention of Relapse in Alcohol‐Dependent Patients: A Randomized, Double‐Blind, Placebo‐Controlled Trial
    Andrea de Bejczy, Kari R. Nations, Armin Szegedi, Joep H. Schoemaker, Frank Ruwe, Bo Söderpalm · 2014 · Alcoholism Clinical and Experimental Research
67. Implantable technology for long-term delivery of nalmefene for treatment of alcoholism
    Lauren C. Costantini, Sofie R. Kleppner, Joseph McDonough, Marc R. Azar, Raj Patel · 2004 · International Journal of Pharmaceutics
68. Naltrexone Treatment for Alcohol Dependence
    Richard K. Fuller, Enoch Gordis · 2001 · New England Journal of Medicine
69. A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study
    Guttorm Raknes, Lars Småbrekke · 2016 · Pharmacoepidemiology and Drug Safety
70. Behavioral, neurobiological, and neurochemical mechanisms of ethanol self-administration: A translational review
    Ashley A. Vena, Shannon L. Zandy, Roberto U. Cofresí, Rueben A. Gonzales · 2020 · Pharmacology & Therapeutics
71. Does Effect Size in Naltrexone Trials for Alcohol Dependence Differ for Single-Site vs. Multi-Center Studies?
    Richard Feinn, Henry R. Kranzler · 2005 · Alcoholism Clinical and Experimental Research
72. Effects of Naltrexone on Neural and Subjective Response to Alcohol in Treatment‐Seeking Alcohol‐Dependent Patients
    Primavera A. Spagnolo, Vijay A. Ramchandani, Melanie L. Schwandt, Lishu Zhang, Sara K. Blaine, Julie M. Usala, Kristie A. Diamond, Monte J. Phillips, David Ted George, Reza Momenan et al. · 2014 · Alcoholism Clinical and Experimental Research
73. Pharmacologic management of relapse prevention in addictive disorders
    Mehmet Sofuoglu, Thomas R. Kosten · 2004 · Psychiatric Clinics of North America
74. Issues with recruitment to randomised controlled trials in the drug and alcohol field: a literature review and Australian case study
    Clare Thomson, Kirsten C. Morley, Maree Teesson, Claudia Sannibale, Paul Haber · 2008 · Drug and Alcohol Review
75. Pharmacogenetics of Addiction Therapy
    David A. Nielsen, Ellen M. Nielsen, Teja Dasari, Catherine J. Spellicy · 2014 · Methods in molecular biology
76. Recent advances in the pharmacotherapy of alcoholism
    Hugh Myrick, Raymond F. Anton · 2004 · Current Psychiatry Reports
77. A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence
    Conor Kevin Farren, Michael M. Scimeca, Ran Wu, S Malley · 2008 · Drug and Alcohol Dependence
78. Continuing care in the treatment of addictive disorders
    James R. McKay · 2006 · Current Psychiatry Reports
79. Reductions in Alcohol Craving Following Naltrexone Treatment for Heavy Drinking
    Amy W. Helstrom, Frederick C. Blow, Valerie J. Slaymaker, Henry R. Kranzler, Shirley H. Leong, David W. Oslin · 2016 · Alcohol and Alcoholism
80. A randomized controlled trial of cognitive remediation and work therapy in the early phase of substance use disorder recovery for older veterans: Neurocognitive and substance use outcomes.
    Morris David Bell, Holly B. Laws, Ismene B. Petrakis · 2016 · Psychiatric Rehabilitation Journal
81. Use of Naltrexone in the Treatment of Alcoholism Nationally in the Department of Veterans Affairs
    Ismene L. Petrakis, DOUGLAS L. LESLIE, Robert Alan Rosenheck · 2003 · Alcoholism Clinical and Experimental Research
82. New pharmacotherapies for alcohol dependence
    Robert Graham, ALEX D. WODAK, Greg Whelan · 2002 · The Medical Journal of Australia
83. Naltrexone (50 mg) Plus Psychotherapy in Alcohol-Dependent Patients: A Meta-Analysis of Randomized Controlled Trials
    Joanna Jarosz, Katarzyna Miernik, Maria Wąchal, Jacek Walczak, Günther Krumpl · 2013 · The American Journal of Drug and Alcohol Abuse
84. Treatment for Co-Morbid Posttraumatic Stress Disorder and Substance Use Disorders
    David S. Riggs, Edna B. Foa · 2007 · Springer eBooks
85. Building Bridges: The Transdisciplinary Study of Craving From the Animal Laboratory to the Lamppost
    Peter M. Monti, Jennifer W. Tidey, Cristine Lynn Czachowski, Kathleen A. Grant, Damaris J. Rohsenow, Michael A. Sayette, Natalie Maners, Peter Pierre · 2004 · Alcoholism Clinical and Experimental Research
86. Naltrexone in the Treatment of Alcohol Dependence
    Ellen M. Unterwald · 2008 · Journal of Addiction Medicine
87. Integrated Management of Physician‐delivered Alcohol Care for Tuberculosis Patients: Design and Implementation
    Shelly F. Greenfield, Alan L. Shields, Hilary Smith Connery, Viktoriya Livchits, Sergey A. Yanov, Charmaine S. Lastimoso, Aivar K. Strelis, Sergey P. Mishustin, Garrett M. Fitzmaurice, Trini Ann Mathew et al. · 2009 · Alcoholism Clinical and Experimental Research
88. A randomized controlled study of the effect of ifenprodil on alcohol use in patients with alcohol dependence
    Nagisa Sugaya, Yasukazu Ogai, Yuzo Aikawa, Yosuke Yumoto, Mihoko Takahama, Miho Tanaka, Ayako Haraguchi, Mitsuru Umeno, Kazutaka Ikeda · 2018 · Neuropsychopharmacology Reports
89. The opioid receptors as targets for drug abuse medication
    Florence Noble, Magalie Lenoir, Nicolas Marie · 2015 · British Journal of Pharmacology
90. A Rational Approach to the Pharmacotherapy of Alcohol Dependence
    Ismene L. Petrakis · 2006 · Journal of Clinical Psychopharmacology
91. Extended-release naltrexone plus medical management alcohol treatment in primary care: findings at 15 months
    Joshua D. Lee, Ellie Grossman, Laura Huben, Marc W. Manseau, Jennifer McNeely, John Rotrosen, David L. Stevens, Marc N. Gourevitch · 2012 · Journal of Substance Abuse Treatment
92. Variable Selection for Optimal Decision Making
    Lacey Gunter, Ji Zhu, Susan A. Murphy · 2007 · Lecture notes in computer science
93. Effects of Naltrexone During the Descending Limb of the Blood Alcohol Curve
    Lara A. Ray, Kent E. Hutchison, James M. MacKillop, Robert Miranda, Amy Audette, Robert M. Swift, Peter M. Monti · 2008 · American Journal on Addictions
94. Effect of the combination of naltrexone and acamprosate on alcohol intake in mice
    Sung-Gon Kim, BYEUNG‐DEUK HAN, JE‐MIN PARK, MYUNG‐JUNG KIM, Michael F. Stromberg · 2003 · Psychiatry and Clinical Neurosciences
95. Interventions in Suicidal Alcoholics
    Jack R. Cornelius, Duncan B. Clark, Ihsan M. Salloum, Oscar Gary Bukstein, Thomas M. Kelly · 2004 · Alcoholism Clinical and Experimental Research
96. Technology transfer and the treatment of addiction: what can research offer practice?
    A. Thomas McLellan · 2002 · Journal of Substance Abuse Treatment
97. A Systematic Review of Naltrexone for Attenuating Alcohol Consumption in Women with Alcohol Use Disorders
    Shantrel S. Canidate, Giselle Carnaby, Christa L Cook, Robert L. Cook · 2017 · Alcoholism Clinical and Experimental Research
98. What works in alcohol use disorders?
    Jason S. Luty · 2006 · Advances in Psychiatric Treatment
99. Use of naltrexone for alcohol use disorders in the Veterans’ Health Administration: A national study
    Theddeus Iheanacho, Mohammed Abdullah Issa, Carla Beth Marienfeld, Robert Alan Rosenheck · 2013 · Drug and Alcohol Dependence
100. Alcohol Dependence: The Impact of Cognitive Behaviour Therapy with or Without Naltrexone on Subjective Health Status
     Gerald F.X. Feeney, Gerald F.X. Feeney, Jason P. Connor, Ross McD. Young, Jane Tucker, Annie McPherson · 2004 · Australian & New Zealand Journal of Psychiatry